Literature DB >> 5093102

Treatment of advanced prostatic carcinoma with Estracyt. A preliminary report.

G Jönsson, B Högberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5093102     DOI： 10.3109/00365597109133586

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN： 0036-5599


× No keyword cloud information.
  11 in total

1.  Estracyt in hormone-resistant prostatic carcinoma.

Authors:  Z Szendröi; I Könyves; L Szendi; S Eckhardt; F Hartay
Journal:  Int Urol Nephrol       Date:  1974       Impact factor: 2.370

2.  Lipofuscin in malignant and non-malignant human prostatic tissue.

Authors:  J Müntzing; T Nilsson
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

3.  Effect of estramustine phosphate (Estracyt) on transplantable mouse tumours.

Authors:  M Wakisaka; I Iwasaki; J Shimazaki
Journal:  Urol Res       Date:  1979-12

4.  Treatment of prostatic cancer with Estracyt (estramustine phosphate).

Authors:  F Balogh; L Kisbenedek
Journal:  Int Urol Nephrol       Date:  1975       Impact factor: 2.370

5.  Difference in uptake of 3H-estramustine in two human prostatic carcinoma cell lines, LNCaP and LNCaP-r.

Authors:  M Hasenson
Journal:  Urol Res       Date:  1989

6.  The hydrolysis of estramustine phosphate; in vitro studies.

Authors:  O Gunnarsson; S B Andersson; S A Johansson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Oct-Dec       Impact factor: 2.441

7.  Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients.

Authors:  P O Gunnarsson; S B Andersson; S A Johansson; T Nilsson; G Plym-Forshell
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.

Authors:  S B Andersson; P O Gunnarsson; T Nilsson; G P Forshell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

9.  Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case series.

Authors:  Gaetano Aurilio; Rossella Graffeo; Vincenzo Bagnardi; Franco Nolè; Laura Adamoli; Olivia Pagani; Elisa Gallerani; Benvenuto Ferrari; Giancarlo Pruneri; Aron Goldhirsch
Journal:  Int J Clin Oncol       Date:  2014-04-12       Impact factor: 3.402

10.  Growth inhibiting effect of estramustine on two prostatic carcinoma cell lines, LNCaP and LNCaP-r.

Authors:  M Hansenson; B Lundh; B Hartley-Asp; A Pousette
Journal:  Urol Res       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.